Epizootics of bovine ephemeral fever on dairy farms in Saudi Arabia.

In 1990 and 1996, field veterinarians suspected the clinical occurrence of bovine ephemeral fever among dairy and conventional cattle in different regions of Saudi Arabia. The disease has a seasonal occurrence; it begins in early summer (May) and ends in late autumn (November). The mortality rate is low: 0.3% to 0.6%. The morbidity rate ranged from 5% to 61% within the different age groups of one affected herd in the 1996 outbreaks and from 3.4% to 19% among four affected herds in the 1990 outbreaks. A sudden sharp drop in milk production occurred in lactating animals, some of which had become dry by the end of the outbreaks. Trials to isolate the causative virus in cell culture and in baby mice were unsuccessful. Serum neutralisation tests, which used a cell culture-adapted vaccine strain of bovine ephemeral fever virus as an antigen, revealed the presence of specific antibodies with significantly increased titres in the convalescent sera of affected animals. In addition, the testing of paired sera from non-affected heifers and from both dry and milking cows, performed twice, with an interval of 21 days, revealed the presence of neutralising antibodies. In the 1990 outbreaks, comparative serological studies indicated a high percentage (67.5%; 27/40) of seropositive animals in herds in which bovine ephemeral fever had been previously suspected. No antibodies were detected in animals of herds which had no recorded clinical history of bovine ephemeral fever. Following serological confirmation of the prevalence of bovine ephemeral fever in Saudi Arabia, some dairy farms started using a live imported vaccine to control the disease. This study discusses the epizootiological findings in regard to bovine ephemeral fever, as well as its economic impact on four affected dairy farms in 1990. In addition, the authors evaluate the efficacy of immunoprophylaxis in another dairy herd during the same outbreaks.

Serological survey of foot and mouth disease in Saudi Arabia.

An immunodiffusion test using foot and mouth disease (FMD) virus infection-associated (VIA) antigen was used to detect precipitating antibodies in serum samples collected from non-vaccinated indigenous ruminants raised in different regions of Saudi Arabia. Of 5,985 sheep sera, 1,371 goat sera, 1,052 cattle sera and 694 serum samples from unspecified species of ruminants, precipitating activity was detected in 1,209 (20%), 127 (9%), 172 (16%) and 38 (5%) samples, respectively. In addition, 100 sera showing precipitating activity against VIA antigen originating from 13 different regions were tested for the presence of naturally-occurring neutralising antibodies against the four serotypes of FMD virus (O, A, Asia 1, and C) currently prevalent in the region and incorporated in the vaccine being used. All sera tested gave varying titres against serotypes O, A and/or Asia 1. However, none of the sera showed neutralising activities against serotype C. The results obtained are interpreted with regard to the geographical distribution and epizootiology of FMD in Saudi Arabia.

Application of double sandwich enzyme-linked immunosorbent assay for the diagnosis of foot-and-mouth disease in Saudi Arabia.

Using foot-and-mouth disease (FMD) diagnostic reagents provided by the FMD-World Reference Laboratory, Pirbright (United Kingdom), an indirect sandwich enzyme-linked immunosorbent assay (ELISA) was applied for local diagnosis of FMD in the Kingdom of Saudi Arabia. Testing epithelial tissues and/or vesicular fluids, it was possible to carry out serotyping of FMD virus before its isolation in cell cultures. All the field samples received as well as the oesophageal pharyngeal fluids collected from apparently healthy animals were inoculated onto primary bovine kidney cell cultures and the isolated FMD viruses then serotyped by ELISA. Testing of samples received from 43 outbreaks revealed positive FMD diagnosis in 29 outbreaks (27 caused by serotype "O" and 2 caused by serotype "A" of FMD virus). In addition, ELISA serotyping of 35 carrier strains of FMD virus (isolated from 286 proband samples) revealed 28 serotype "O" and 7 serotype "A" FMD viral isolates. The results are discussed concerning the importance of applying local FMD diagnosis and the current epizootiological status of the disease in Saudi Arabia.

Development of a live cell culture camelpox vaccine.

A Saudi isolate of camel orthopoxvirus was serially propagated on monolayers of camel kidney cell cultures. The attenuation of the 78th passage was tested in two susceptible camels. Two other susceptible camels were inoculated with vaccinia virus four times propagated in camel kidney cell cultures. The four inoculated camels showed no postinoculation clinical symptoms and formed neutralizing antibodies against both the camel orthopox and vaccinia viruses. No postchallenge clinical symptoms were observed in these four camels, while two non-inoculated contact control camels showed typical symptoms of generalized camelpox. These results indicated the safety and potency of the 78th passage of the Saudi isolate of camel orthopoxvirus (designated Jouf-78) to be used for production of live attenuated cell culture camelpox vaccine. The field testing of the vaccine was carried out on two farms using at least 10(3) TCID50 as a recommended field dose. None of the inoculated camels showed any postvaccination reaction and the serological tests showed seroconversion of many vaccinated field camels. The relationship between camel orthopoxvirus and vaccinia virus as well as the advantages of the live attenuated camelpox vaccine are discussed.